Loading company…
Won 5 federal SBIR/STTR research awards from HHS and other federal agencies.
CARDIAC RSK3 INHIBITORS, LLC has been awarded 5 US Small Business Innovation Research (SBIR/STTR) contracts totalling $10,485,488 between 2019 and 2023. These are non-dilutive federal research grants, not equity financing. The company is based in Los Altos, California.
5 rounds · latest SBIR Phase II award (HHS), Sep 2023
Sign in to see 5 rounds.
Sign inNo investors recorded yet for CARDIAC RSK3 INHIBITORS, LLC.
Add an investorCARDIAC RSK3 INHIBITORS, LLC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for CARDIAC RSK3 INHIBITORS, LLC.
Add diversity data